ERBB2 and breast cancer: To further validate the relevance of this finding to the human setting, we also analysed scRNA-seq data from a cohort of 26 primary breast tumours67 of the three major clinical breast cancer subtypes (ER+, TNBC and HER2+) sampled from patients undergoing surgery.